ViroPharma Inc.

A House bill that is intended to join a package of drug pricing measures moving through Congress this year attempts to address one of the thorniest and longest-standing complaints about patent defense

GlaxoSmithKline's multiple myeloma candidate, Scynexis's treatment for invasive candidiasis caused by the emerging global health threat Candida auris , and Takeda/Shire's maribavir for cytomegaloviru

Strasbourg, France-based Dynacure may only have been set up two years ago, but in some ways it is a "mature start up", and has been able to raise a hefty €47m ($55m) from VCs and institutional inves

Gilead Sciences Inc. has promoted Andrew Dickinson to executive vice president, corporate development and strategy, effective immediately. Dickinson will become a member of Gilead’s senior leader